Home > Stocks & Markets > HealthcareZIOPHARM Oncology IncMost RecentCompany & Industry OverviewsHow Did Ziopharm Keep XBI from Losing More Ground?Year-to-date, Ziopharm has a return of -12.5%. Ziopharm has a book value of $0.72. With its current price, the stock is trading at a PBV ratio of 10.1x.
Company & Industry OverviewsHow Did Ziopharm Keep XBI from Losing More Ground?Year-to-date, Ziopharm has a return of -12.5%. Ziopharm has a book value of $0.72. With its current price, the stock is trading at a PBV ratio of 10.1x.
